Series B startup

Who invested in Akarna Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2016, from 1 source

Latest round
Series B, $15MFeb 2016
Investors
1
See who backed them

The rounds

  1. Feb 2016
    Series B$15M

    Source recorded

Everyone who backed them

Forbion Capital PartnersPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Akarna Therapeutics

Who invested in Akarna Therapeutics?

Akarna Therapeutics's investors include Forbion Capital Partners.

How much has Akarna Therapeutics raised?

Akarna Therapeutics has raised $15M across 1 round since 2016.

When did Akarna Therapeutics last raise?

Akarna Therapeutics's most recent round was a Series B of $15M in Feb 2016.

What was Akarna Therapeutics's biggest round?

Its most recent round, $15M in Feb 2016, is also its largest on record.

Who backed Akarna Therapeutics first?

Akarna Therapeutics's first round on record, in Feb 2016, was backed by Forbion Capital Partners.

What stage is Akarna Therapeutics at?

Akarna Therapeutics's latest named round is a Series B, in Feb 2016.

Companies like Akarna Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.